Strategic Precision in Life Sciences.
FJHERMANN CONSULTING advises pharmaceutical, biotech, medtech, and healthcare innovation leaders on the medical, scientific, and commercial decisions that shape a therapy's path from early development to market.
Scientific depth. Strategic judgment. Commercial understanding.
Scientific depth, strategic judgment, and commercial understanding.
FJHERMANN CONSULTING is an independent Life Sciences boutique based in Zurich, operating at the intersection of medicine, scientific strategy, and commercial execution.
The boutique supports senior leaders in biotech, pharma, MedTech, and healthcare innovation in making complex medical and strategic decisions — with medically grounded scientific depth, senior-level entrepreneurial judgment, and uncompromising precision and discretion.
Three focused areas of counsel
Every engagement is grounded in scientific rigor and clinical insight, structured around the areas that matter most to life sciences leadership.
Medical & Clinical Consulting
Medical-scientific advisory spanning oncology and other complex therapeutic areas — connecting rigorous clinical and scientific analysis with medical affairs, clinical development, and stakeholder communication.
- Medical-scientific advisory and therapy area analysis, including oncology strategy
- Clinical development support — trial strategy, protocol review, and endpoint alignment
- Medical affairs strategy, advisory board planning, and scientific communication
- Analysis and translation of medical, clinical, and scientific insight for internal and external audiences
Commercialization & Market Access
Strategic and operational support to bring products, therapies, and innovations to market — from positioning and stakeholder engagement to market access and launch readiness.
- Commercialization strategy and go-to-market planning
- Market access strategy and payer / stakeholder engagement
- Positioning, communication, and training for product and therapy initiatives
- Stakeholder engagement across investors, partners, and cross-functional teams
Digital Health, AI & Connected Infrastructure
Advisory support for selected digital health, artificial intelligence, and software / SaaS initiatives — extending, where relevant, to smart building and connected infrastructure projects for healthcare and life sciences organizations.
- Digital health and AI advisory for pharma, biotech, and medtech companies
- Agentic systems, software, and SaaS model advisory
- Support for healthcare innovation and technology initiatives
- Selected smart building, automation, and connected infrastructure advisory
Scope of Activities
FJHERMANN CONSULTING provides advisory and professional services in the fields of medicine, clinical development, medical affairs, scientific strategy, commercialization, market access, and pharmaceutical, biotechnology, and healthcare innovation. The practice supports medical-scientific advisory work, strategic and operational support for healthcare, pharma, and biotech companies, the analysis and translation of medical, clinical, and scientific insights, product, therapy, and innovation initiatives, and support for positioning, communication, training, and stakeholder engagement. In addition, the firm supports selected digital health, artificial intelligence, agentic systems, software, and SaaS-related innovation initiatives for companies in pharma, biotech, medtech, and healthcare.
Frank Jürgen Hermann
Frank Jürgen Hermann, MD, EMBA, founded FJHERMANN CONSULTING in Zurich to give life sciences leaders direct access to senior, physician-led strategic counsel — combining medical training with executive business qualification.
His boutique draws on international experience across medicine, clinical development, medical affairs, and commercial strategy, supporting organizations in navigating complex scientific and business decisions with clarity and rigor.
He works directly and discreetly with a limited number of clients at a time, bringing senior-level attention to every engagement.
Where clinical detail meets strategic execution
Oncology Strategy
Medical and scientific strategy for oncology and other complex therapeutic areas.
Clinical Development
Trial strategy, protocol review, and endpoint alignment across development phases.
Medical Affairs
Advisory board planning, scientific communication, and stakeholder engagement.
Scientific Strategy
Translating complex scientific insight into coherent, defensible strategy.
Market Access
Value positioning and launch readiness across global markets.
Digital Health & AI
Advisory on digital health, AI, and software/SaaS initiatives for healthcare.
Engagement formats
Mandates are scoped to the question at hand — from a focused review to ongoing senior counsel.
Strategy Reviews
Focused, time-boxed review of a clinical, medical, or commercial strategy.
Advisory Board Support
Planning, moderation, and synthesis of medical or scientific advisory boards.
Positioning & Evidence Narrative
Structuring the scientific and commercial narrative behind a product or therapy.
Digital Health & AI Advisory
Assessment and strategic input on digital health, AI, or SaaS initiatives.
Fractional Senior Counsel
Ongoing senior counsel on a fractional or retained basis.
Investor & Board Translation
Translating complex scientific data for investors, boards, or non-specialist stakeholders.
Considering a Strategic Advisory Partner?
Discuss your medical, scientific, or commercial challenge in a confidential first conversation.
Start the conversation
Reach the Zurich boutique directly to arrange a confidential first conversation.
Zurich Boutique
FJHERMANN CONSULTING is based in Zurich, Switzerland, and advises clients internationally. All engagements are subject to confidentiality by default.
Request a Consultation Discuss a Project Brief